News
Alumni News: GOAL-3 wins MIT Solve Global Health Challenge 2025
We are proud to share that GOAL 3, Venture Challenge Fall 2019 alumnus, has been selected as one of the six winners of the MIT Solve Global Health Challenge 2025 with its digital health platform IMPALA.
Henri Termeer Fellowship 2026: Leadership Programme for Early-Stage Biotech CEOs
The Termeer Institute, an organisation dedicated to empowering life sciences leaders and continuing the legacy of Henri Termeer, has opened applications for its 2026 Fellowship Programme.
Alumni News: Sencilia (Venture Challenge Spring 2023) secures investment from Future Tech Ventures and imec.istart.nl
MedTech startup Sencilia, alumnus of the Venture Challenge Spring 2023, has secured an investment from Future Tech Ventures and imec.istart.nl to advance the development of its Rely-V® infusion monitoring sensor technology.
Three Venture Challenge teams selected for Biotech Booster 2025 cohort
We’re proud to share that three recent Venture Challenge teams have been selected for the Biotech Booster 2025 cohort: Lumox (Sebas Pronk)
Applications Open for BioBusiness Masterclass 2025–2026!
Are you a biotech founder, team lead, or early-career professional eager to scale your impact?
Bridge for Impact returns this October!
On Tuesday, 7 October 2025, Bridge for Impact returns to Utrecht for another inspiring afternoon of entrepreneurial support, knowledge exchange, and networking in the Life Sciences & Health sector.
Alumni News: Team Capsule Photonics officially incorporated under the name Lumeniris
We’re thrilled to share that Capsule Photonics, winner of the Venture Challenge Winter 2024/2025, has officially incorporated under the name Lumeniris.
Stem Cell Nasal Drops Offer Hope for Babies with Brain Injury
NeuroNova Tx - Winner of the most recent Venture Challenge - is making headlines with groundbreaking research that changes the lives of babies born with brain damage. Oxygen deprivation around birth can lead to serious and lasting brai
Alumni News: Fetch (Winner Venture Challenge Spring 2024) Acquired by Tzu Cancer Therapeutics
Amsterdam, 17 July 2025 – We’re proud to share that Fetch B.V., winner of the Venture Challenge Spring 2024, has been acquired by Tzu Cancer Therapeutics B.V., a biotech company focused
Alumni News: InnoFluidics Wins Gerard & Anton Award 2025
We’re thrilled to celebrate our Venture Challenge Fall 2021 alumnus InnoFluidics, who was honored this week as one of Brainport Eindhoven’s most promising startups of 2025!